A Hybrid Cellular Automaton Model of Solid Tumor Growth and Bioreductive Drug Transport

No abstract is available for this paper.

• Publication year

  2012

• Venue

  IEEE/ACM Transactions on Computational Biology & Bioinformatics

• Publication date

  2012-11-01

• Fields of study

  Medicine, Chemistry, Engineering, Computer Science

• Identifiers
  DOI 10.1109/TCBB.2012.118PMID 23221082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Extracting Rules From Neural Networks as Decision Diagrams

  2011cited by this paper
• Handbook of Physiology; a Critical, Comprehensive Presentation of Physiological Knowledge and Concepts

  2011cited by this paper
• Intelligent Modelling for Benign Tumour Growth with Cell-Cell and Cell-Matrix Adhesion and Movement

  2010cited by this paper
• In silico cancer modeling: is it ready for prime time?

  2009cited by this paper
• Cellular automaton modeling of biological pattern formation

  2009cited by this paper
• Cellular automata as microscopic models of cell migration in heterogeneous environments.

  2008cited by this paper
• An evolutionary hybrid cellular automaton model of solid tumour growth.

  2007cited by this paper
• Metabolic changes during carcinogenesis: potential impact on invasiveness.

  2007cited by this paper
• A mathematical model of breast cancer development, local treatment and recurrence.

  2007cited by this paper
• Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs.

  2006cited by this paper
• Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment.

  2006cited by this paper
• Mathematical modelling of cancer cell invasion of tissue

  2005cited by this paper
• A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion.

  2005cited by this paper
• Tumor microenvironmental physiology and its implications for radiation oncology.

  2004cited by this paper
• A history of the study of solid tumour growth: The contribution of mathematical modelling

  2004cited by this paper
• Modeling and Computer Simulations of Tumor Growth and Tumor Response to Radiotherapy

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion.

  2003cited by this paper
• Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.

  2003cited by this paper
• Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.

  2002cited by this paper
• A Cellular Automaton Model of Early Tumor Growth and Invasion: The Effects of Native Tissue Vascularity and Increased Anaerobic Tumor Metabolism

  2001cited by this paper
• USING MATHEMATICS TO STUDY SOLID TUMOUR GROWTH

  2001cited by this paper
• A cellular automaton model of early tumor growth and invasion.

  2001cited by this paper
• Neural Model of the Genetic Network*

  2001cited by this paper
• Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies.

  2000cited by this paper
• ADVECTION-DIFFUSION MODELS FOR SOLID TUMOUR EVOLUTION IN VIVO AND RELATED FREE BOUNDARY PROBLEM

  2000cited by this paper
• Extracellular matrix concentration exerts selection pressure on invasive cells.

  1999cited by this paper
• Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model

  1999cited by this paper
• Application of neural networks in medicine - a review

  1998cited by this paper
• An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours.

  1997cited by this paper
• Multicellular membranes as an in vitro model for extravascular diffusion in tumours.

  1996cited by this paper
• Growth of nonnecrotic tumors in the presence and absence of inhibitors.

  1995cited by this paper
• Does tirapazamine (SR-4233) have any cytotoxic or sensitizing effect on three human tumour cell lines at clinically relevant partial oxygen pressure?

  1995cited by this paper
• Analysis of growth of multicellular tumour spheroids by mathematical models

  1994cited by this paper
• Tumor growthin vivo and as multicellular spheroids compared by mathematical models

  1994cited by this paper
• SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.

  1993cited by this paper
• Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH

  1992cited by this paper
• Fingerprint processing using back propagation neural networks

  1990cited by this paper
• Intracellular signalling as a parallel distributed process.

  1990cited by this paper
• Role of necrosis in regulating the growth saturation of multicellular spheroids.

  1988cited by this paper
• Glucose diffusivity in multicellular tumor spheroids.

  1988cited by this paper
• Proliferative and clonogenic heterogeneity of cells from EMT6/Ro multicellular spheroids induced by the glucose and oxygen supply.

  1986cited by this paper
• Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply.

  1986cited by this paper
• Analysis, forecasting, and control of three-dimensional tumor growth and treatment

  1984cited by this paper
• Oxygen diffusivity in tumor tissue (DS-carcinosarcoma) under temperature conditions within the range of 20--40 degrees C.

  1977cited by this paper
• Oxygen diffusivity in tumor tissue (DS-Carcinosarcoma) under temperature conditions within the range of 20–40°C

  1977cited by this paper
• Mathematical Modelling of Tumour Invasion and Metastasis

  year unknowncited by this paper

• Geometric immunosuppression in CAR T-cell treatment: Insights from mathematical modeling

  2025cites this paper
• Image-based biomarkers for engineering neuroblastoma patient-specific computational models

  2024cites this paper
• Development of a coupled modeling for tumor growth, angiogenesis, oxygen delivery, and phenotypic heterogeneity

  2023cites this paper
• Innovations in integrating machine learning and agent-based modeling of biomedical systems

  2022cites this paper
• Combining Machine Learning and Agent-Based Modeling to Study Biomedical Systems

  2022influential citation
• A Spatial Quantitative Systems Pharmacology Platform spQSP-IO for Simulations of Tumor–Immune Interactions and Effects of Checkpoint Inhibitor Immunotherapy

  2021cites this paper
• Characterization of reversible intermediate boundary cellular automata

  2020cites this paper
• Modelling biochemical engineering processes related to cell populations

  2019cites this paper
• Safety and efficacy of tirapazamine as anti-cancer drug: a meta-analysis of randomized controlled trials

  2018cites this paper
• Modeling three-dimensional invasive solid tumor growth in heterogeneous microenvironment under chemotherapy

  2018cites this paper
• An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids

  2018cites this paper
• The spatial distribution and dynamics of CXCL13 in lymphoid tissues

  2017cites this paper
• Agent-Based Models of the Tumor Microenvironment: PredictingFlow-Mediated Invasion and Cancer Viability in Response toInterstitial Flow, Chemotherapy, and Stromal Cell Density

  2017cites this paper
• Fuzzy-CA model for an in-silico cancer cell line: A journey from simple cellular pattern to an emergent complex behavior

  2016cites this paper
• The promises of quantitative systems pharmacology modelling for drug development

  2016cites this paper
• Reversibility Problem of Multidimensional Finite Cellular Automata

  2016cites this paper
• An in silico model to demonstrate the effects of Maspin on cancer cell dynamics.

  2016cites this paper
• Reversibility of general 1D linear cellular automata over the binary field Z2 under null boundary conditions

  2015cites this paper
• Agent‐Based Modeling in Systems Pharmacology

  2015cites this paper
• 2D CAT Based Modeling of Tumour Growth and Drug Transport

  2015cites this paper
• Integrated PK-PD and agent-based modeling in oncology

  2015cites this paper
• The effects of non-inhibitory serpin maspin on cell migration using an artificial neural network

  2014cites this paper
• Optimal intermittent dose schedules for chemotherapy using genetic algorithm

  2013cites this paper
• A hybrid computational model for the effects of maspin on cancer cell dynamics.

  2013cites this paper